Changes in Coagulation Testing During a National Shortage of Blue-Top Tubes.
Hannah G SchuettOksana VolodAnders H BergKyu RheeSam S TorbatiRichard V RiggsDavid P FrishbergPublished in: American journal of clinical pathology (2022)
Interventions resulting in significant reductions were in divisions with effective management and supervision. Success in navigating the BTT shortage stemmed from timely announcements, action, and effective communication. Our recommendations established more effective coagulation assay utilization, decreased overall BTT use, and prevented patients with coagulopathic disorders from experiencing adverse consequences.